Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of quetiapine SR compared to
placebo in increasing time from randomisation to an anxiety event in patients with
generalised anxiety disorder (GAD).
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation
was changed to XR after consultation with FDA.